NewAmsterdam Pharma Company
NAMS
#3720
Rank
$2.67 B
Marketcap
$24.95
Share price
-2.35%
Change (1 day)
44.81%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Cash on Hand

Cash on Hand as of September 2024 : $0.42 Billion USD

According to NewAmsterdam Pharma Company's latest financial reports the company has $0.42 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NewAmsterdam Pharma Company - Cash on Hand chart (from 2023 to 2023)

202220232024$0.1B$0.2B$0.3B$0.4B$0.5B$0.6Bcompaniesmarketcap.com

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.34 B-32.14%
2022-12-31$0.50 B636.99%
2021-12-31$68.07 M472.44%
2020-12-31$11.89 M